C

Changzhou Qianhong Biopharma Co Ltd
SZSE:002550

Watchlist Manager
Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
Watchlist
Price: 9.2 CNY -1.92% Market Closed
Market Cap: 11.8B CNY

Wall Street
Price Targets

Price Targets Summary
Changzhou Qianhong Biopharma Co Ltd

There are no price targets for Changzhou Qianhong Biopharma Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Changzhou Qianhong Biopharma Co Ltd Competitors:
Price Targets
CRON
Cronos Group Inc
13% Downside
002422
Sichuan Kelun Pharmaceutical Co Ltd
16% Upside
EMCURE
Emcure Pharmaceuticals Ltd
23% Upside
570
China Traditional Chinese Medicine Holdings Co Ltd
21% Downside
688513
Chengdu Easton Biopharmaceuticals Co Ltd
3% Upside
ARVN
Arvinas Inc
80% Upside
214370
Caregen Co Ltd
7% Upside
3933
United Laboratories International Holdings Ltd
2% Upside

Revenue
Forecast

Revenue Estimate
Changzhou Qianhong Biopharma Co Ltd

For the last 8 years the compound annual growth rate for Changzhou Qianhong Biopharma Co Ltd's revenue is 9%. The projected CAGR for the next 3 years is 24%.

9%
Past Growth
24%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Changzhou Qianhong Biopharma Co Ltd

For the last 8 years the compound annual growth rate for Changzhou Qianhong Biopharma Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 23%.

11%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-39%
Average Miss

Net Income
Forecast

Net Income Estimate
Changzhou Qianhong Biopharma Co Ltd

For the last 8 years the compound annual growth rate for Changzhou Qianhong Biopharma Co Ltd's net income is 6%. The projected CAGR for the next 2 years is 14%.

6%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-22%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Changzhou Qianhong Biopharma Co Ltd's stock price target?
Not Available

Changzhou Qianhong Biopharma Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Changzhou Qianhong Biopharma Co Ltd's Revenue forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for Changzhou Qianhong Biopharma Co Ltd's revenue is 9%. The projected CAGR for the next 3 years is 24%.

What is Changzhou Qianhong Biopharma Co Ltd's Operating Income forecast?
Projected CAGR
23%

For the last 8 years the compound annual growth rate for Changzhou Qianhong Biopharma Co Ltd's operating income is 11%. The projected CAGR for the next 3 years is 23%.

What is Changzhou Qianhong Biopharma Co Ltd's Net Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Changzhou Qianhong Biopharma Co Ltd's net income is 6%. The projected CAGR for the next 2 years is 14%.

Back to Top